158
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Structural and biochemical analysis of human inositol monophosphatase-1 inhibition by ebselen

ORCID Icon, , , , , , & show all
Pages 14036-14048 | Received 23 Sep 2022, Accepted 30 Jan 2023, Published online: 10 Feb 2023

References

  • Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., McCoy, A. J., Moriarty, N. W., Oeffner, R., Read, R. J., Richardson, D. C., Richardson, J. S., Terwilliger, T. C., & Zwart, P. H. (2010). PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallographica. Section D, Biological Crystallography, 66(Pt 2), 213–221. https://doi.org/10.1107/S0907444909052925
  • Agam, G., Bersudsky, Y., Berry, G. T., Moechars, D., Lavi-Avnon, Y., & Belmaker, R. H. (2009). Knockout mice in understanding the mechanism of action of lithium. Biochemical Society Transactions, 37(Pt 5), 1121–1125. https://doi.org/10.1042/BST0371121
  • Amporndanai, K., Meng, X., Shang, W., Jin, Z., Rogers, M., Zhao, Y., Rao, Z., Liu, Z.-J., Yang, H., Zhang, L., O'Neill, P. M., & Samar Hasnain, S. (2021). Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives. Nature Communications, 12(1), 3061. https://doi.org/10.1038/s41467-021-23313-7
  • Atack, J. R. (1995). Inositol monophosphatase inhibitors: A novel treatment for bipolar disorder? Biological Psychiatry, 37(11), 761–763. https://doi.org/10.1016/0006-3223(95)00020-H
  • Atack, J. R. (1997). Inositol monophosphatase inhibitors–lithium mimetics? Medicinal Research Reviews, 17(2), 215–224. https://doi.org/10.1002/(sici)1098-1128(199703)17:2 < 215::aid-med3 > 3.0.co;2-2
  • Atack, J. R., Broughton, H. B., & Pollack, S. J. (1995). Inositol monophosphatase–a putative target for Li + in the treatment of bipolar disorder. Trends in Neurosciences, 18(8), 343–349. https://doi.org/10.1016/0166-2236(95)93926-o
  • Belmaker, R. H., Bersudsky, Y., Agam, G., Levine, J., & Kofman, O. (1996). How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory. Annual Review of Medicine, 47(1), 47–56. https://doi.org/10.1146/annurev.med.47.1.47
  • Berridge, M. J., & Irvine, R. F. (1984). Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature, 312(5992), 315–321. https://doi.org/10.1038/312315a0
  • Berridge, M. J., Downes, C. P., & Hanley, M. R. (1989). Neural and developmental actions of lithium: A unifying hypothesis. Cell, 59(3), 411–419. https://doi.org/10.1016/0092-8674(89)90026-3
  • BIOVIA. (2019). Dassault Systèmes, BIOVIA Discovery Studio Visualizer, v19.1.0.18287. San Diego: Dassault Systèmes.
  • Bone, R., Frank, L., Springer, J. P., & Atack, J. R. (1994). Structural studies of metal binding by inositol monophosphatase: Evidence for two-metal ion catalysis. Biochemistry, 33(32), 9468–9476. https://doi.org/10.1021/bi00198a012
  • Bone, R., Frank, L., Springer, J. P., Pollack, S. J., Osborne, S. A., Atack, J. R., Knowles, M. R., McAllister, G., Ragan, C. I., & Broughton, H. B. (1994). Structural analysis of inositol monophosphatase complexes with substrates. Biochemistry, 33(32), 9460–9467. https://doi.org/10.1021/bi00198a011
  • Chiou, J., Wan, S., Chan, K.-F., So, P.-K., He, D., Chan, E. W-c., Chan, T-h., Wong, K-y., Tao, J., & Chen, S. (2015). Ebselen as a potent covalent inhibitor of New Delhi metallo-β-lactamase (NDM-1). Chemical Communications (Cambridge, England), 51(46), 9543–9546.
  • Davis, I. W., Leaver-Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J., Richardson, J. S., & Richardson, D. C. (2007). MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Research, 35(Web Server issue), W375–383. https://doi.org/10.1093/nar/gkm216
  • de Munnik, M., Lohans, C. T., Lang, P. A., Langley, G. W., Malla, T. R., Tumber, A., Schofield, C. J., & Brem, J. (2019). Targeting the Mycobacterium tuberculosis transpeptidase Ldt Mt2 with cysteine-reactive inhibitors including ebselen. Chemical Communications (Cambridge, England), 55(69), 10214–10217.
  • Demissie, M., Hanlon, C., Birhane, R., Ng, L., Medhin, G., & Fekadu, A. (2018). Psychological interventions for bipolar disorder in low- and middle-income countries: Systematic review. BJPsych Open, 4(5), 375–384. https://doi.org/10.1192/bjo.2018.46
  • Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010). Features and development of Coot. Acta Crystallographica. Section D, Biological Crystallography, 66(Pt 4), 486–501. https://doi.org/10.1107/S0907444910007493
  • Evans, P. (2006). Scaling and assessment of data quality. Acta Crystallographica. Section D, Biological Crystallography, 62(Pt 1), 72–82. https://doi.org/10.1107/S0907444905036693
  • Favrot, L., Grzegorzewicz, A. E., Lajiness, D. H., Marvin, R. K., Boucau, J., Isailovic, D., Jackson, M., & Ronning, D. R. (2013). Mechanism of inhibition of Mycobacterium tuberculosis antigen 85 by ebselen. Nature Communications, 4(1), 2748. https://doi.org/10.1038/ncomms3748
  • Fenn, G. D., Waller-Evans, H., Atack, J. R., & Bax, B. D. (2020). Crystallization and structure of ebselen bound to Cys141 of human inositol monophosphatase. Acta Crystallographica. Section F, Structural Biology Communications, 76(Pt 10), 469–476. https://doi.org/10.1107/S2053230X20011310
  • Ferrari, A. J., Stockings, E., Khoo, J.-P., Erskine, H. E., Degenhardt, L., Vos, T., & Whiteford, H. A. (2016). The prevalence and burden of bipolar disorder: Findings from the Global Burden of Disease Study 2013. Bipolar Disorders, 18(5), 440–450. https://doi.org/10.1111/bdi.12423
  • Ganzhorn, A. J., Lepage, P., Pelton, P. D., Strasser, F., Vincendon, P., & Rondeau, J. M. (1996). The contribution of lysine-36 to catalysis by human myo-inositol monophosphatase. Biochemistry, 35(33), 10957–10966. https://doi.org/10.1021/bi9603837
  • Ganzhorn, A., & Rondean, J. (1997). Structure of an enzyme-substrate complex and the catalytic mechanism of human brain myo-inositol monophosphatase. Protein Engineering, 10, 61–61.
  • Gee, N. S., Ragan, C. I., Watling, K. J., Aspley, S., Jackson, R. G., Reid, G. G., Gani, D., & Shute, J. K. (1988). The purification and properties of myo-inositol monophosphatase from bovine brain. The Biochemical Journal, 249(3), 883–889. https://doi.org/10.1042/bj2490883
  • Gill, R., Mohammed, F., Badyal, R., Coates, L., Erskine, P., Thompson, D., Cooper, J., Gore, M., & Wood, S. (2005). High-resolution structure of myo-inositol monophosphatase, the putative target of lithium therapy. Acta Crystallographica. Section D, Biological Crystallography, 61(Pt 5), 545–555. https://doi.org/10.1107/S0907444905004038
  • Gore, M., Greasley, P., McAllister, G., & Ragan, C. (1993). Mammalian inositol monophosphatase: The identification of residues important for the binding of Mg2+ and Li + ions using fluorescence spectroscopy and site-directed mutagenesis. Biochemical Journal, 296(3), 811–815.
  • Greasley, P. J., & Gore, M. G. (1993). Bovine inositol monophosphatase. Studies on the binding interactions with magnesium, lithium and phosphate ions. FEBS Letters, 331(1-2), 114–118. https://doi.org/10.1016/0014-5793(93)80308-h
  • Greasley, P. J., Hunt, L. G., & Gore, M. G. (1994). Bovine inositol monophosphatase. Ligand binding to pyrene-maleimide-labelled enzyme. European Journal of Biochemistry, 222(2), 453–460. https://doi.org/10.1111/j.1432-1033.1994.tb18885.x
  • Hallcher, L. M., & Sherman, W. R. (1980). The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. Journal of Biological Chemistry, 255(22), 10896–10901.
  • Herschlag, D., & Jencks, W. P. (1990). Catalysis of the hydrolysis of phosphorylated pyridines by Mg (OH)+: A possible model for enzymic phosphoryl transfer. Biochemistry, 29(21), 5172–5179.
  • Jackson, R. G., Gee, N. S., & Ragan, C. I. (1989). Modification of myo-inositol monophosphatase by the arginine-specific reagent phenylglyoxal. The Biochemical Journal, 264(2), 419–422. https://doi.org/10.1042/bj2640419
  • Jacob, C., Maret, W., & Vallee, B. L. (1998). Ebselen, a selenium-containing redox drug, releases zinc from metallothionein. Biochemical and Biophysical Research Communications, 248(3), 569–573. https://doi.org/10.1006/bbrc.1998.9026
  • Kabsch, W. (2010). XDS. Acta Crystallographica. Section D, Biological Crystallography, 66(Pt 2), 125–132. https://doi.org/10.1107/S0907444909047337
  • Knowles, M. R. (1992). Bovine inositol monophosphatase. Modification, identification and mutagenesis of reactive cysteine residues. The Biochemical Journal, 285(Pt 2), 461–468. https://doi.org/10.1042/bj2850461
  • Kraft, L., Roe, S. M., Gill, R., & Atack, J. R. (2018). Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690,330. Acta Crystallographica. Section D, Structural Biology, 74(Pt 10), 973–978. https://doi.org/10.1107/S2059798318010380
  • Kraft, L., Roe, S. M., Gill, R., & Atack, J. R. (2018). Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690,330. Acta Crystallographica Section D, 74(10), 973–978. https://doi.org/10.1107/S2059798318010380
  • Lu, S., Huang, W., Li, X., Huang, Z., Liu, X., Chen, Y., Shi, T., & Zhang, J. (2012). Insights into the role of magnesium triad in myo-inositol monophosphatase: Metal mechanism, substrate binding, and lithium therapy. Journal of Chemical Information and Modeling, 52(9), 2398–2409. https://doi.org/10.1021/ci300172r
  • Martini, F., Bruning, C. A., Soares, S. M., Nogueira, C. W., & Zeni, G. (2015). Inhibitory effect of ebselen on cerebral acetylcholinesterase activity in vitro: Kinetics and reversibility of inhibition. Current Pharmaceutical Design, 21(7), 920–924. https://doi.org/10.2174/1381612820666141014124319
  • McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007). Phaser crystallographic software. Journal of Applied Crystallography, 40(Pt 4), 658–674. https://doi.org/10.1107/S0021889807021206
  • McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M., & Geddes, J. R. (2012). Lithium toxicity profile: A systematic review and meta-analysis. Lancet (London, England), 379(9817), 721–728. https://doi.org/10.1016/S0140-6736(11)61516-X
  • Menendez, C. A., Bylehn, F., Perez-Lemus, G. R., Alvarado, W., & de Pablo, J. J. (2020). Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease. Science Advances 6(37), eabd0345. https://doi.org/10.1126/sciadv.abd0345
  • Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997). Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallographica. Section D, Biological Crystallography, 53(Pt 3), 240–255. https://doi.org/10.1107/S0907444996012255
  • Niesen, F. H., Berglund, H., & Vedadi, M. (2007). The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nature Protocols, 2(9), 2212–2221. https://doi.org/10.1038/nprot.2007.321
  • O'Leary, V., & Solberg, M. (1976). Effect of sodium nitrite inhibition on intracellular thiol groups and on the activity of certain glycolytic enzymes in Clostridium perfringens. Applied and Environmental Microbiology, 31(2), 208–212. https://doi.org/10.1128/aem.31.2.208-212.1976
  • Patel, S., Martınez-Ripoll, M., Blundell, T. L., & Albert, A. (2002). Structural enzymology of Li+-sensitive/Mg2+-dependent phosphatases. Journal of Molecular Biology, 320(5), 1087–1094.
  • Pelton, P. D., & Ganzhorn, A. J. (1992). The effect of histidine modification on the activity of myo-inositol monophosphatase from bovine brain. Journal of Biological Chemistry, 267(9), 5916–5920.
  • Perlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., Reilly-Harrington, N. A., Nierenberg, A. A., Sachs, G. S., & Thase, M. E. (2006). Predictors of recurrence in bipolar disorder: Primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). The American Journal of Psychiatry, 163(2), 217–224. https://doi.org/10.1176/appi.ajp.163.2.217
  • Petra, P. H., Cohen, W., & Shaw, E. N. (1965). Isolation and characterization of the alkylated histidine from TLCK inhibited trypsin. Biochemical and Biophysical Research Communications, 21(6), 612–618. https://doi.org/10.1016/0006-291x(65)90530-9
  • Pollack, S. J., Knowles, M. R., Atack, J. R., Broughton, H. B., Ragan, C. I., Osborne, S., & McAllister, G. (1993). Probing the role of metal ions in the mechanism of inositol monophosphatase by site-directed mutagenesis. European Journal of Biochemistry, 217(1), 281–287. https://doi.org/10.1111/j.1432-1033.1993.tb18244.x
  • Rees-Milton, K. J., Greasley, P. J., Ragan, C. I., & Gore, M. G. (1993). Bovine inositol monophosphatase. FEBS Letters, 321(1), 37–40. https://doi.org/10.1016/0014-5793(93)80616-3
  • Rose, N. R., Thalhammer, A., Seden, P. T., Mecinović, J., & Schofield, C. J. (2009). Inhibition of the histone lysine demethylase JMJD2A by ejection of structural Zn (II). Chemical Communications, 42, 6376–6378.
  • Rydzik, A. M., Brem, J., Struwe, W. B., Kochan, G. T., Benesch, J. L. P., & Schofield, C. J. (2014). Ejection of structural zinc leads to inhibition of gamma-butyrobetaine hydroxylase. Bioorganic & Medicinal Chemistry Letters, 24(21), 4954–4957. https://doi.org/10.1016/j.bmcl.2014.09.035
  • Schwarz, J. (2016). Atypical elements in drug design. Springer.
  • Sies, H. (1995). Methods in enzymology (Vol. 252, pp. 341–342). Elsevier.
  • Singh, N., Halliday, A. C., Knight, M., Lack, N. A., Lowe, E., & Churchill, G. C. (2012). Cloning, expression, purification, crystallization and X-ray analysis of inositol monophosphatase from Mus musculus and Homo sapiens. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications, 68(Pt 10), 1149–1152. https://doi.org/10.1107/S1744309112035191
  • Singh, N., Halliday, A. C., Thomas, J. M., Kuznetsova, O. V., Baldwin, R., Woon, E. C. Y., Aley, P. K., Antoniadou, I., Sharp, T., Vasudevan, S. R., & Churchill, G. C. (2013). A safe lithium mimetic for bipolar disorder. Nature Communications, 4(1), 1332. https://doi.org/10.1038/ncomms2320
  • Singh, N., Sharpley, A. L., Emir, U. E., Masaki, C., Herzallah, M. M., Gluck, M. A., Sharp, T., Harmer, C. J., Vasudevan, S. R., Cowen, P. J., & Churchill, G. C. (2016). Effect of the putative lithium mimetic ebselen on brain myo-inositol, sleep, and emotional processing in humans. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 41(7), 1768–1778. https://doi.org/10.1038/npp.2015.343
  • Thorne, M. R., Greasley, P. J., & Gore, M. G. (1996). Bovine inositol monophosphatase: Enzyme-metal-ion interactions studied by pre-equilibrium fluorescence spectroscopy. The Biochemical Journal, 315(Pt 3), 989–994. https://doi.org/10.1042/bj3150989
  • Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
  • Vedadi, M., Niesen, F. H., Allali-Hassani, A., Fedorov, O. Y., Finerty, P. J., Wasney, G. A., Yeung, R., Arrowsmith, C., Ball, L. J., Berglund, H., Hui, R., Marsden, B. D., Nordlund, P., Sundstrom, M., Weigelt, J., & Edwards, A. M. (2006). Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination. Proceedings of the National Academy of Sciences of the United States of America, 103(43), 15835–15840. https://doi.org/10.1073/pnas.0605224103
  • Vieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018). Bipolar disorders. Nature Reviews. Disease Primers, 8(4), 18008. https://doi.org/10.1038/nrdp.2018.8
  • Wagner, G., Schuch, G., Akerboom, T. P., & Sies, H. (1994). Transport of ebselen in plasma and its transfer to binding sites in the hepatocyte. Biochemical Pharmacology, 48(6), 1137–1144. https://doi.org/10.1016/0006-2952(94)90150-3
  • Waldron, T. T., & Murphy, K. P. (2003). Stabilization of proteins by ligand binding:  Application to drug screening and determination of unfolding energetics. Biochemistry, 42(17), 5058–5064. https://doi.org/10.1021/bi034212v
  • Walther, M., Holzhütter, H. G., Kuban, R. J., Wiesner, R., Rathmann, J., & Kühn, H. (1999). The inhibition of mammalian 15-lipoxygenases by the anti-inflammatory drug ebselen: Dual-type mechanism involving covalent linkage and alteration of the iron ligand sphere. Molecular Pharmacology, 56(1), 196–203. https://doi.org/10.1124/mol.56.1.196
  • Wang, J., Wang, P., Dong, C., Zhao, Y., Zhou, J., Yuan, C., & Zou, L. (2020). Mechanisms of ebselen as a therapeutic and its pharmacology applications. Future Medicinal Chemistry, 12(23), 2141–2160.
  • Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., McNicholas, S. J., Murshudov, G. N., Pannu, N. S., Potterton, E. A., Powell, H. R., Read, R. J., Vagin, A., & Wilson, K. S. (2011). Overview of the CCP4 suite and current developments. Acta Crystallographica. Section D, Biological Crystallography, 67(Pt 4), 235–242. https://doi.org/10.1107/S0907444910045749
  • Yalçın, G., & Yılmaz, Ş. (2004). Determination of ebselen by HPLC: Validation and application of the method. Chromatographia, 60, 583–587.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.